Investigations on the occurrence of infections with hepatitis E virus and related viruses in zoo animals by Spahr, Carina
 
From the Institute of Virology 





Investigations on the occurrence of infections with  






to obtain the degree of a 
Doctor medicinae veterinariae (Dr. med. vet.) 
























Mit Genehmigung der Veterinärmedizinischen Fakultät der Universität Leipzig 
 
 





Dekan: Prof. Dr. Dr. Thomas Wilhelm Vahlenkamp 
Betreuer 1: Prof. Dr. Dr. Thomas Wilhelm Vahlenkamp 
Betreuer 2: Prof. Dr. Reimar Johne 
  
Gutachter 1: Prof. Dr. Dr. Thomas Wilhelm Vahlenkamp, Universität 
Leipzig, Leipzig 
Gutachter 2: Prof. Dr. Reimar Johne, Bundesinstitut für Risikobewertung, 
Berlin-Marienfelde 
Gutachter 3: Prof. Dr. Paul Becher, Stiftung Tierärztliche Hochschule 
Hannover, Hannover 
List of content 
 I 
List of content 
List of content ............................................................................................................. I 
List of figures ............................................................................................................ III 
List of tables ............................................................................................................. IV 
List of abbreviations ................................................................................................. V 
1 General introduction .......................................................................................... 1 
1.1 Discovery of HEV .......................................................................................... 1 
1.2 Taxonomy ..................................................................................................... 3 
1.3 Morphology ................................................................................................... 4 
1.4 Genomic organisation ................................................................................... 5 
1.5 Viral replication ............................................................................................. 6 
1.6 Hepatitis E in humans ................................................................................... 8 
1.7 Tools for HEV diagnosis ............................................................................. 10 
1.8 Therapy ....................................................................................................... 10 
1.9 Animal infections with HEV and HEV-like viruses ....................................... 11 
1.10 Experimental infections of animals ............................................................. 14 
1.11 Geographical distribution ............................................................................ 14 
1.12 Transmission pathways .............................................................................. 16 
1.13 Epidemiology .............................................................................................. 17 
1.14 Prevention ................................................................................................... 18 
2 Aims of the study ............................................................................................. 20 
3 Publications ...................................................................................................... 22 
3.1 Publication I ................................................................................................ 22 
3.1.1 Summary of Publication I ..................................................................... 22 
3.1.2 Key messages of Publication I ............................................................. 23 
3.1.3 Own contribution to Publication I ......................................................... 23 
3.2 Publication II ............................................................................................... 43 
3.2.1 Summary of Publication II .................................................................... 43 
3.2.2 Key messages of Publication II ............................................................ 44 
3.2.3 Own contribution to Publication II ........................................................ 44 
3.3 Publication III .............................................................................................. 51 
3.3.1 Summary of Publication III ................................................................... 51 
3.3.2 Key messages of Publication III ........................................................... 52 
3.3.3 Own contribution to Publication III ....................................................... 52 
List of content 
 II 
4 General discussion .......................................................................................... 59 
4.1 HEV infections in various animal species .................................................... 59 
4.2 Prevalence of natural HEV infections in non-human primates .................... 61 
4.3 Prevalence of natural HEV infections in other zoo-housed mammals ........ 64 
4.4 Transmission pathways of HEV in a zoo-setting ......................................... 69 
4.5 Risk of virus transmission from zoo animals to humans ............................. 71 
5 Conclusion and perspectives .......................................................................... 73 
6 Summary ........................................................................................................... 75 
7 Zusammenfassung ........................................................................................... 77 
8 References ........................................................................................................ 79 
List of animals investigated in the study .............................................................. 98 
List of publications ................................................................................................ 102 
Acknowledgements ............................................................................................... 105 
 
  
List of figures 
 III 
List of figures 
Figure 1: TEM picture of HEV from German wild boar. ............................................... 5 
Figure 2: Genomic organisation of mammalian, avian and fish HEV. ......................... 6 
Figure 3: Replication cycle of HEV. ............................................................................. 7 
Figure 4: Time course of HEV infection in humans. .................................................... 9 
Figure 5: Important discoveries about HEV in humans and animals. ........................ 13 
Figure 6: Geographical distribution of HEVs. ............................................................ 15 
Figure 7: Transmission routes of human-pathogenic HEV-GTs. ............................... 16 
Figure 8: Number of recorded annual HE cases in Germany. .................................. 18 
Figure 9: Possible transmission pathways of HEV in a zoo-setting. ......................... 71 
 
  
List of tables 
 IV 
List of tables 
Table 1: Taxonomic classification of HEV within the family Hepeviridae. .................... 4 
Table 2: Natural HEV infections in birds. ................................................................... 60 
Table 3: HEV infections in non-human primates. ...................................................... 64 
Table 4: Natural HEV infections in mammals. ........................................................... 69 
 
  
List of abbreviations 
 V 
List of abbreviations 
 
A 
 ab antibodies 
 ALT Alanine transaminase 
 anti-HEV-ab anti-HEV-antibodies 
 AST Aspartate aminotransferase 
   
B 
 BfR Bundesinstitut für Risikobewertung 
 BLSD big liver and spleen disease 
   
C 
 °C degree Celsius 
 CTV cutthroat trout virus 
 CVUA Chemisches und Veterinäruntersuchungsamt  
   
E 
 e.g. for example (exempli gratia) 
 ELISA enzyme-linked immunosorbent assay 
 ET-NANBH enterically transmitted NANBH 
   
F 
 FLI Friedrich-Loeffler Institut 
   
G 
 g gram 
 gamma-GT gamma-glutamyltransferase 
 GT genotype 
 GTs genotypes 
   
H 
 HAV hepatitis A virus 
 HBV hepatitis B virus 
 HE hepatitis E 
 HEV hepatitis E virus 
List of abbreviations 
 VI 
 HEV-1 to HEV-7 HEV genotypes 1 to -7 
 HEV-Ab EIA HEV-antibody ELISA 
 HEV-GT hepatitis E virus genotype 
 HEV-GTs hepatitis E virus genotypes 
 HEVs hepatitis E viruses 
   
I 
 ICTV International Committee on Taxonomy of 
Viruses 
 IgG immunoglobulin G 
 IgM immunoglobulin M 
   
K 
 kb kilo bases 
   
N 
 NANBH non-A-/non-B hepatitis 
 NBS-RT-PCR nested broad-spectrum RT-PCR 
 nt nucleotide 
   
O 
 ORF open reading frame 
 ORFs open reading frames 
   
P 
 PCR polymerase chain reaction 
 PEI Paul-Ehrlich-Institut 
   
R 
 RdRp RNA-dependent RNA polymerase 
 RKI Robert-Koch-Institut 
 RNA ribonucleic acid 
 RT-PCR reverse transcription polymerase chain 
reaction 
 RT-qPCR reverse transcription real-time polymerase 
chain reaction 
List of abbreviations 
 VII 
   
T 
 TEM Transmission electron microscopic 
   
U 
 USA United States of America 
   
V   
 VLPs virus-like particles 
   
W 




1 General introduction 
 1 
1 General introduction 
Hepatitis E is mainly a self-limiting human disease, basically characterised by 
acute or chronic hepatitis, which is caused by infection with the hepatitis E virus (HEV) 
(KAMAR et al. 2015; REIN et al. 2012). Large outbreaks have been described in 
developing countries, where hepatitis E is known to be endemic (PURCELL and 
EMERSON 2008). However, the disease is also increasingly recognised in 
industrialised countries like Germany e.g., with 3.275 notified HE cases in 2018 and it 
is grouped into emerging infectious diseases (PURCELL and EMERSON 2008; RKI 
2019). Generally, the case fatality rate is low, ranging between 1–4%, though mortality 
rates up to 25% have been described for pregnant women during fulminant outbreaks 
in endemic regions (KAMAR et al. 2012; KUMAR et al. 2013; KHUROO et al. 1995). 
Dependent on the distinct genotype, hepatitis E viruses particularly can be transmitted 
zoonotically or by the consumption of faecally contaminated water, undercooked meat 
and sausage products (PAVIO et al. 2017). Domestic pig (Sus scrofa domestica) and 
wild boar (Sus scrofa) represent the major reservoirs for human-pathogenic, zoonotic 
genotypes (GTs) 3 and 4 (PAVIO et al. 2010). Besides domestic pig and wild boar, 
HEV or HEV-related viruses have been detected in several other domestic, wildlife, pet 
and zoo animal species (DÄHNERT et al. 2018; JOHNE et al. 2014; ZHANG et al. 
2008). 
1.1 Discovery of HEV 
During the 1970s and the 1980s, multiple hepatitis outbreaks enforced the 
development of novel sensitive and specific diagnostic tools for the identification of 
human infections with hepatitis A (HAV) and hepatitis B virus (HBV). However, the 
novel diagnostic tools failed to determine the causative agents in certain cases 
(KHUROO 1980; WONG et al. 1980). Thus, the unidentified virus causing human 
hepatitis was named non-A-/non-B hepatitis (NANBH) virus (REYES et al. 1990). 
In 1980, KHUROO (1980) and WONG et al. (1980) reasserted the hypothesis 
of the existence of a NANBH virus transmitted by the faecal-oral route. Neither antigens 
nor antibodies (ab) of both, HAV and HBV were identified as the aetiological agent of 
the hepatitis outbreak in Kashmir Valley, India (KHUROO 1980). The authors therefore 
assumed the existence of an additional virus causing hepatitis in humans (KHUROO 
1980). According to epidemiological analysis, a stream used as resource for drinking 
water was strongly indicated as the source of infection (KHUROO 1980). Retrospective 
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investigations of human sera from New Delhi, India, date the first HEV outbreak in 
1955 (WONG et al. 1980). The Delhi epidemic (1955–1956), the Ahmedabad epidemic 
(1975–1976) and some sporadic hepatitis cases in Pune (1978–1979) were 
epidemiologically associated with faecally contaminated drinking water (WONG et al. 
1980). The number of hepatitis cases with unknown aetiological agent increased and 
evidence was growing for the existence of an enterically transmitted virus (ET-NANBH) 
similar to HAV, but yet unknown, being responsible for a major proportion of hepatitis 
cases in India (BALAYAN et al. 1983). 
In 1983, about 30.000 persons were sickened by a water-borne hepatitis 
infection nearby Tashkent, caused by ET-NANBH (BALAYAN et al. 1983). After an 
experimental faecal-oral infection of Mikhail Balayan himself, the Russian Scientologist 
and his team were able to purify and visualise virus-like particles (VLPS) with diameters 
of 27 to 30 nm in stool samples, using immune electron microscopy (BALAYAN et al. 
1983). Five years later, in 1988, the virus was given its current name “hepatitis E virus” 
by PURCELL and TICEHURST (1988). Furthermore, the molecular characterisation 
and cloning of the genome was successfully reached in 1990/1991 for the first time 
(REYES et al. 1990; TAM et al. 1991). 
In the same year, BALAYAN and his colleagues (1990) first claimed the 
possibility of a zoonotic HEV transmission when the experimental transmission of a 
human HEV strain resulted in the successful infection of a domestic pig. The first 
animal strain (swine HEV) was detected in domestic pigs from the United States seven 
years later (MENG et al. 1997). Since swine HEV and human HEV are closely related 
to each other, a zoonotic way of transmission was now more evident (ERKER et al. 
1999; MENG et al. 1997). 
A HEV-like virus associated with Big Liver and Spleen Disease (BLSD) was 
discovered in chicken (Gallus gallus domesticus) from Australia and designated as 
avian HEV in the year 2001 (HANDLINGER and WILLIAMS 1988; HAGSHENAS et al. 
2001; PAYNE et al. 1999). BLSD is associated with decreased egg production and a 
slightly increased mortality in chicken flocks (GERBER et al. 2014; RITCHIE and 
RIDDELL 1991). In 2010, rat HEV was first identified in Norway rats (Rattus 
norvegicus) from Hamburg, Germany, using a broad-spectrum RT-PCR assay 
(EASTERBROOK et al. 2007; JOHNE et al. 2010a; JOHNE et al. 2010b). This virus 
was subsequently detected worldwide in different rat species (LI et al. 2013b; 
MULYANTO et al. 2014; PURCELL et al. 2011). Another virus, widely spread in 
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spawning adult trout from California, USA, was first detected in 1991 (HEDRICK et al. 
1991). The virus could be isolated in cell culture and was termed the cutthroat trout 
virus (CTV) (HEDRICK et al. 1991). In 2011, genome sequence analyses of CTV lead 
to the affiliation into the family Hepeviridae, since then known as fish HEV (BATTS et 
al. 2011). Avian, rat and fish HEV seem to be mainly host-specific with no or low 
potential of zoonotic transmission to humans. 
1.2 Taxonomy 
HEV was first classified within the family Caliciviridae due to structural and 
genomic similarities (BRADLEY and BALAYAN 1988; OKAMOTO 2007). In 2005, the 
genus Hepevirus was created, but not assigned to any virus family (EMERSON et al. 
2005). This genus comprised two species: the hepatitis E virus, containing the 
mammalian HEV isolates, and a tentative species containing avian hepatitis E virus 
(EMERSON et al. 2005). Soon after, a new taxonomic proposal created the new family 
Hepeviridae, including the genus Hepevirus and the type species hepatitis E virus 
(MAYO and BALL 2006). Since a large variety of HEV-like viruses was identified in 
animals and humans between 2001 and 2014, Smith et al. suggested to divide the 
family Hepeviridae into two genera: Orthohepevirus and Piscihepevirus (SMITH et al. 
2014) (Tab. 1). Instead, the genus Hepevirus was deleted. 
Currently, the International Committee on Taxonomy of Viruses (ICTV) assigns 
all human, mammalian and avian GTs to the genus Orthohepevirus, whereas the 
genus Piscihepevirus only contains one single species from cutthroat trout 
(Oncorhynchus clarkii) and related fish species (ICTV 2014) (Tab. 1). The genus 
Orthohepevirus is associated with for species, containing in turn various genotypes: 
Orthohepevirus A (isolates from mammals: human, domestic pig, wild boar, rabbit, 
deer, mongoose dromedary and Bactrian camel), Orthohepevirus B (isolates from 
chicken), Orthohepevirus C (isolates from Norway rat, black rat, greater bandicoot, 
Asian musk shrew, ferret, mink and red fox) and Orthohepevirus D (isolates from 
different bat species) (SMITH et al. 2014) (Tab. 1). Eight genotypes are assigned to 
the species Orthohepevirus A: HEV-1 and HEV-2 (restricted to humans), zoonotic 
HEV-3 (human, domestic pig, wild boar, rabbit, deer, mongoose), zoonotic HEV-4 
(humans, domestic pig, wild boar), HEV-5 and HEV-6 (restricted to wild boar), zoonotic 
HEV-7 (dromedary camel and human) and HEV-8 (Bactrian camel) (NIDAIRA et al. 
2012) (Tab. 1). Orthohepevirus B consists of avian HEV that are divided into four 
proposed subtypes (I-IV) (SMITH et al. 2014). HEV-C1 (isolates from rats) and HEV-
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C2 (isolates from wild carnivores: ferret, mink, red fox) are assessed to the species 
Orthohepevirus C (SMITH et al. 2014) (Tab. 1). Orthohepevirus D strains have been 
detected in various bat species (DREXLER et al. 2012; SMITH et al. 2014) (Tab. 1). 
 
 
*, no genotype existing. 
Table 1: Taxonomic classification of HEV within the family Hepeviridae. 
1.3 Morphology 
The hepatitis E virus is a small non-enveloped RNA-virus with an icosahedral 
capsid of about 27 to 34 nm in diameter (MENG et al. 2010). Recent analyses suggest 
the presence of an additional outer membrane in a fraction of HEV particles in patient 
sera and cell culture supernatant (YIN et al. 2016). The virus’ morphology resembles 
the morphology of caliciviruses (Fig. 1). The virus particle is mainly composed of the 
capsid protein encoded by the open reading frame (ORF) 2. Enveloped particles 
additionally contain the small phosphoprotein encoded by ORF3 (JOHNE et al. 2014). 
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With permission from Dr. Valerij Akimkin, CVUA, Stuttgart, Germany, 2014. 
Figure 1: TEM picture of HEV from German wild boar. 
1.4 Genomic organisation 
The viral genome consists of a linear, single-stranded RNA with positive polarity 
and a length of 6.6–7.3 kb (kilo bases) (RYLL et al. 2017). The genome contains typical 
sequence elements of an eukaryotic mRNA: it is capped at the 5´-end with 7-
methylguanosine and polyadenylated at the 3´-end (KABRANE-LAZIZI et al. 1999; 
REYES et al. 1990; TAM et al. 1991). The regions adjacent to the poly A-tail and the 
cap structure are non-coding regions, which seem to have essential influence on the 
viral replication and protein translation (CAO et al. 2012; CHANDRA et al. 2008; TAM 
et al. 1991). The virus genome contains three major open reading frames (ORF1, 
ORF2 and ORF3) (JOHNE et al. 2014). Strains of genotype HEV-C1 (rat HEV and 
ferret HEV) contain an additional open reading frame (ORF4), overlapping with the 5’-
region of ORF1. The genome of avian HEV is 600 base pairs shorter compared to 
mammalian HEV or fish HEV and shares only 50% nucleotide (nt) sequence identity 
with them. A schematic presentation of the genomes of mammalian, avian and fish 
HEV is presented in Fig. 2. 
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Adapted from MENG 2016; 
CRE, cis-reactive element; Hel, helicase; HVR, hypervariable region; MT, methyltransferase;  
NCR, non-coding regions; ORFs, open reading frames; P, papain-like cysteine protease;  
RdRp, RNA-dependent RNA polymerase; X, macro domain. 
Figure 2: Genomic organisation of mammalian, avian and fish HEV. 
The ORF1 is the largest part of the genome with 4.6–5.2 kb, positioned at the 
5´-end of the genomic map and directly translated (MENG et al. 2010). It encodes one 
polyprotein, which in turn is processed into various non-structural proteins with 
enzymatic activities (MENG et al. 2010). Between ORF1 and ORF3, there is a junction 
region for mammalian HEV and avian HEV, containing a stem-loop structure and a cis-
reactive element (CRE), which initiates the synthesis of a sub genomic mRNA 
encoding ORF2 and ORF3. 
ORF2 encodes the capsid protein of 600–675 amino acids, with binding activity 
to cell surface heparin sulphate proteoglycans (YAMASHITA et al. 2009). This capsid 
protein is positioned at the 3´-end of the genome. The capsid protein is capable of self-
assembly into virus-like particles (CHANDRA et al. 2008). 
The ORF3 overlaps with ORF2 and encodes a small phosphoprotein of largely 
varying length in avian, mammalian and fish HEV (HOLLA et al. 2013; JOHNE et al. 
2014; ZAFRULLAH et al. 1997). Functions in viral infectivity and immunosuppression 
of the host have been suggested (CHANDRA et al. 2008). ORF4 is an additional ORF 
of 522 nt, only described for rat HEV and ferret HEV. This ORF4 overlaps with ORF1 
at its 5´-end and its function is still unknown (JOHNE et al. 2010b; RAJ et al. 2012). 
1.5 Viral replication 
HEV is a hepatotropic virus mainly infecting hepatocytes and Kupffer cells of the 
liver (LEE et al. 2009). The virus replication cycle is shown schematically in Fig. 3. 
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Adapted from CAO and MENG 2012; 
ER: endoplasmatic reticulum; putative attachment receptors: HSPGs, heparin sulphate proteoglycans;  
HSC70, heat shock cognate protein 70; HSP90, heat shock cognate protein 90;  
GrP78, glucose-regulated protein 78; NSP, non-structural polyprotein; Golgi, Golgi apparatus. 
Figure 3: Replication cycle of HEV.  
Primarily, the HEV particle binds to the cell surface using heparin sulphate 
proteoglycans and a still unknown receptor molecule before entering the cell. The viral 
RNA is then released from the capsid into the cytoplasm with the help of heat shock 
protein 90 and glucose-regulated protein 78 (CAO and MENG 2012). The released 
positive-sense genomic RNA serves as a template for translation of the ORF1-
encoded non-structural polyprotein (NSP), which is subsequently processed by cellular 
proteases (CHANDRA et al. 2008). One product of the NSP is the viral RNA-dependent 
RNA polymerase (RdRp). An ER transmembrane domain in the RdRp is involved in 
the replication complex of HEV and interacts with the 3´-end of the genomic HEV RNA 
(AGGARWAL et al. 2001). In the first replication cycle, the positive strand is transcribed 
into a negative strand. This negative strand serves as template for the genomic positive 
strand and for the sub genomic positive strand in a second replication cycle. The 
structural proteins (capsid protein and phosphoprotein) encoded by ORF2 and ORF3 
are then translated from this bicistronic sub genomic RNA (GRAFF et al. 2006). The 
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ORF2-encoded capsid protein thereafter packages the genomic viral RNA and new 
virions are assembled (CAO and MENG 2012). Thereafter, progeny virions are 
transported to the cell membrane and exit the infected liver cells by the help of the 
ORF3-encoded phosphoprotein (CAO and MENG 2012). It has been suggested that 
the released HEV particles originally contain a membrane derived from the cell and 
associated with the ORF3 protein, which is removed by bile salts and trypsin during 
the egress of the virus through the bile duct and intestine (OKAMOTO 2013; 
OKAMOTO, 2011). Therefore, HEV particles shed by stool are non-enveloped 
(OKAMOTO 2013; OKAMOTO, 2011). 
1.6 Hepatitis E in humans 
HEV represents one of the five major human hepatotropic viruses (hepatitis A–
E), which primarily affect the liver. In particular, infection with HEV is the most common 
cause for acute hepatitis in humans worldwide (REIN et al. 2012). Annually about 3.5 
million patients worldwide come up with an acute hepatitis caused by HEV proceeding 
to lethal disease in more than 65,000 cases and 3,000 stillbirths (REIN et al. 2012). 
After incubation for two to eight weeks, mild to moderate influenza-like symptoms arise 
at first, developing to emesis, fever, pain of the limbs, headache or epigastralgia, 
before signs of acute hepatitis can occur. On the basis of clinical symptoms only, 
hepatitis E is hard to distinguish from other viral infections causing hepatitis or non-
infectious liver diseases due to abuse of alcohol or medication, toxins, storage 
diseases, Alpha 1-antitrypsin deficiency or autoimmune hepatitis (RKI 2015). 
Hepatomegaly and increased levels of the liver enzymes bilirubin, alanine 
transaminase (ALT) and gamma-glutamyltransferase (gamma-GT) are indicators for 
an acute liver disease (PAVIO et al. 2010). These changes of the liver function occur 
within 4–6 weeks post infection and are often accompanied by decolouration of the 
stool and dark urine (SCHIELKE 2011). 
Generally, the case/fatality rate is low, ranging between 0.2% and 4% (KUMAR 
et al. 2013). In developing countries, large outbreaks of hepatitis E may occur due to 
improper hygiene, leading to faecal contamination of drinking water with HEV. In these 
countries, the HEV-IgG seroprevalence within adults ranges between 30–80% (WHO 
2015). For endemic regions as China, India, Somalia and Uganda, high mortality rates 
up to 25% have been observed in pregnant women with fulminant hepatitis after 
infection with HEV genotype 1 (KAMAR et al. 2012). In contrast, sporadic 
asymptomatic cases of human hepatitis are common in industrialised European 
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countries (ADLHOCH et al. 2016). These cases are still comparatively rare, but the 
disease is also increasingly recognised during the past ten years (ADLHOCH et al. 
2016). Here, the HEV-IgG seroprevalence ranges between 16% (Southwestern 
England) and 53% (Southwestern France) (FABER et al. 2012). 
The disease is mostly self-limiting, and the patients fully recover after a few 
weeks (FABER et al. 2012). However, chronic HEV infections, which may develop to 
liver cirrhosis, have been repeatedly described in immunosuppressed transplant 
patients after infection with HEV genotype 3 (KAMAR et al. 2015; KAMAR et al. 2014b; 
KAMAR et al. 2013). 
Since HEV does not cause a cytopathic effect in liver cells or hepatocyte 
cytolysis, hepatitis E is assumed to be an immune-mediated disease, which is induced 
by the host immune response against the infected liver cells (PAVIO et al. 2010). The 
viremic phase starts in the prodromal stage, about 2 weeks after infection, when HEV-
RNA can be detected in serum (Fig. 4). About one week later, viral excretion via faeces 
begins, continuing until 2–3 weeks after the onset of jaundice (PAVIO et al. 2010). 
Clinical symptoms and liver enzyme values usually decrease within 6 weeks (Fig. 4). 
IgM ab are first detected in serum after about 2 weeks post infection; however, their 
concentration declines within 3 months. IgG ab occur in parallel or later and may persist 
for several years (Fig. 4). 
 
Adapted from PEREZ-GRACIA et al. 2015. 
Figure 4: Time course of HEV infection in humans. 
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1.7 Tools for HEV diagnosis 
The haemograms of human patients with clinical symptomatology typically show 
increased levels of AST and ALT, which are disproportionately high compared to the 
increase of AP and gamma-GT (RKI 2015). Especially for icteric disease courses, the 
serum bilirubin level, and the urobilinogen level, are significantly elevated (RKI 2015). 
Several immunoassays (e.g. ELISA’s or western blots) are available for the 
detection of HEV antigens or HEV-specific IgG or IgM ab (SCHIELKE 2011). Acute 
HEV infection in humans is typically detected, using HEV-specific IgM ab ELISAs. For 
HEV diagnosis in animals, the use of anti-HEV-IgG ELISAs is more common. However, 
to date, there is no immunoassay, which serves as “gold standard” for the detection of 
HEV-specific ab. 
Nowadays HEV diagnosis is mostly done using molecular methods, such as 
conventional, nested or real time reverse transcription polymerase chain reaction (RT-
PCR) (JOTHIKUMAR et al. 2006; SCHIELKE 2011). Several real time RT-PCR 
protocols enable the detection of the four major human-pathogenic GTs HEV-1 to 
HEV-4 (JOTHIKUMAR et al. 2006). A nested broad-spectrum RT-PCR can be used 
for the broad detection of HEV strains from species Orthohepevirus A, B and C 
(JOHNE et al. 2010b). Several other specific RT-PCR assays have been developed, 
e.g. for detection of rat HEV (WOLF et al. 2013). 
Generally, it is also possible to detect HEV via isolation in cell culture. However, 
this diagnostic tool has no relevance for routine laboratory diagnosis, as it is very 
sophisticated, time-consuming and mostly not successful (RKI 2015). Other 
techniques like electron microscopy and immunohistochemical staining techniques are 
only used sporadically for demonstration of HEV in specific tissue samples (RKI 2015). 
1.8 Therapy 
Ribavirin monotherapy, what is also successfully used for therapy of HIV and 
HCV, has repeatedly been described as an effective drug that inhibits the replication 
of HEV in vivo and induces a sustained antiviral response in immunocompromised 
transplant patients with chronic HEV infections (DEBING et al. 2014; KAMAR et al. 
2014a; KAMAR et al. 2010). Although it has been shown to be effective in several 
patients, in Germany the hepatitis E therapy with ribavirin has no approval yet (ANON. 
2017; LEE et al. 2016; SRIDHAR et al. 2015). 
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1.9 Animal infections with HEV and HEV-like viruses 
Domestic pig, wild boar, rabbit (Oryctolagus cuniculus) and dromedary camel 
(Camelus dromedarius) are known as the main reservoirs of the zoonotic genotypes 
HEV-3, -4 and -7 (ABRAVANEL et al. 2017; DOCEUL et al. 2016; MENG et al. 2009). 
Transmission of HEV-3 from deer to humans has also been described repeatedly, 
although deer most probably undergoes “spillover infections” from wild boar, rather 
than being a true reservoir (ANHEYER-BEHMENBURG et al. 2017; MATSUURA et al. 
2007; TEI et al. 2003). The HEV infection in animals seems to be generally 
asymptomatic (DE CARVALHO et al. 2013). 
In 1997, the first animal strain of HEV, swine HEV, was detected in domestic 
pigs from the United States (MENG et al. 1997) (Fig. 5). In the following years, several 
studies from different countries (USA, New Zealand, Mexico, Spain, France) gave 
evidence for a worldwide distribution of HEV in domestic pigs (CARUSO et al. 2016; 
DOCEUL et al. 2016; PAVIO et al. 2010). The reported anti-HEV-IgG seroprevalences 
in swine herds are usually high, ranging between 23% and 100%, with increasing 
seroprevalence with higher age, suggesting that HEV is enzootic in swine herds all 
over the world (CARUSO et al. 2016; DOCEUL et al. 2016; PAVIO et al. 2010). Anti-
HEV-antibodies (anti-HEV-ab) or HEV-RNA can be detected in sera, faeces, slurry or 
livers of infected pigs. The close relationship between swine HEV and human HEV 
strains led to the assumption, that zoonotic transmission may be possible (VAN DER 
POEL et al. 2001). Therefore, domestic pigs are regarded as the most important 
reservoir of HEV (SCHIELKE 2011). Successful experimental transmission of HEV-3 
strains to domestic pigs and non-human primates provided evidence for zoonotic 
transmission of human-pathogenic HEV strains (DE CARVALHO et al. 2013; XU et al. 
2014). 
As anti-HEV-ab were repeatedly detected in domestic pigs, it was speculated, 
that wild boars may represent a reservoir for HEV, too (DOCEUL et al. 2016; JOHNE 
et al. 2014; KACI et al. 2008). The detection of HEV-RNA in sera, bile, faeces or liver 
from wild boars in different countries supported this hypothesis (MENG 2010). The first 
genome of a wild boar HEV strain from Japan was published in 2004 (SONODA et al. 
2004) (Fig. 5). Another four years later, wild boar HEV was even detected in the 
European wild boar population (KABA et al. 2010; MARTELLI et al. 2008, REUTER et 
al. 2009). Besides domestic pigs, wild boars are regarded as the second most 
important animal reservoir of HEV. 
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Mongoose and rabbit are also known as animal reservoirs of HEV-3. For the 
first time, anti-HEV-3-ab and a full HEV-3 genome sequence were detected in Javan 
mongooses (Herpestes javanicus) from Okinawa, Japan in 2006, suggesting that these 
animals represent an additional reservoir for HEV-3 (LI et al. 2006; NAKAMURA et al. 
2006) (Fig. 5). In 2009, anti-HEV-ab and HEV-RNA were detected in 57.0% (191/335) 
and 7.5% (25/335) of the sera from farmed rex rabbits (Oryctolagus cuniculus 
domesticus) from China, respectively (ZHAO et al. 2009). Subsequently, the new HEV 
genotype was named rabbit HEV (ZHAO et al. 2009) (Fig. 5). In 2014, rabbit HEV was 
grouped as a distinct subtype of HEV-3 (SMITH et al. 2014). HAMMERSCHMIDT et 
al. (2017) succeeded in the detection of anti-HEV-3-antibodies in European brown 
hares (Lepus europaeus). HEV-RNA was also detected in livers from wild rabbits 
(HAMMERSCHMIDT et al. 2017). 
A new human-pathogenic HEV-GT (HEV-7) was recently described in 
dromedary camels from the Middle East, which seems to be widely distributed among 
these animals (RASCHE et al. 2016; WOO et al. 2014) (Fig. 5). Evidence for the 
zoonotic potential of HEV-7 was given in 2016, when it was detected in a chronically 
infected transplant patient from the United Arab Emirates, who regularly consumed 
camel meat and milk (LEE et la. 2016; SRIDHAR et al. 2017). 
Rat HEV was first detected in Norway rats from Germany, in 2010, and 
subsequently in different rat species, worldwide (JOHNE et al. 2012; RYLL et al. 2017; 
WIDÉN et al. 2014). Primarily, host specificity of rat HEV was suggested and 
evidenced, using experimentally infected laboratory rats and other mammals 
(COSSABOOM et al. 2012; LI et al. 2013c). The detection of rat HEV in bandicoot rats 
and Asian musk shrews, however, suggested a broader host range or common 
“spillover infections” (GUAN et al. 2013; MULYANTO et al. 2013; RYLL et al. 2017). 
Therefore, rats have been suspected as HEV animal reservoir for several years, 
besides the main reservoirs of zoonotic genotypes HEV-3, -4 and -7, (LI et al. 2013a; 
LI et al. 2013b; RYLL et al. 2017). Although some serological reports gave incidence 
for a zoonotic potential of rat HEV and in contrast, few Norway rats were reported to 
be HEV-3 positive, rats are still discussed controversially as a potential zoonotic 
reservoir (DREMSEK et al. 2012; LACK et al. 20120; KANAI et al. 2012). 
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Figure 5: Important discoveries about HEV in humans and animals. 
Additional HEV-like viruses have been detected in a wide range of animal 
species, including chicken, fish, bat, ferret, mink and fox (HSU and TSAI et al. 2014; 
KROG et al. 2013; RAJ et al. 2012) (Fig. 5). This includes detections in wild, farmed 
and zoo animals (BODEWES et al. 2013; PERALTA et al. 2009; ZHANG et al. 2008a). 
So far, these viruses show only a distant genetic relationship to the human-pathogenic 
genotypes and are therefore suspected to have a low potential of transmission to 
humans. However, the general involvement of a large variety of animal species in the 
HEV transmission cycles and their involvement in virus transmission to humans have 
not been determined so far. 
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1.10 Experimental infections of animals 
Experimental infections of various animals with different HEV species and 
genotypes have been used to assess the infection routes, excretion, host range, organ 
tropism and pathogenesis of viruses and the vaccine efficiency (DOCEUL et al. 2016). 
Domestic pigs and various non-human primate species, among them 
macaques, tamarin, langur monkey and chimpanzee (Pan troglodytes), served as 
excellent primary model organisms for successful infections with HEV 1–4, including 
zoonotic infections (ARANKALLE et al. 1988; MA et al. 2009; TSAREV et al. 1995; 
TSAREV et al. 1994; VITRAL et al. 1998; YU et al. 2010). Non-human primates 
infected intravenously with high doses of HEV show typical clinical symptoms 
resembling those of human hepatitis E, e.g. elevation of liver enzymes, viremia and 
seroconversion (YUGO et al. 2014; TICEHURST et al. 1992). 
A variety of animal species served as models to assess the zoonotic character 
of HEV-3 and HEV-4. HEV-3 strains from human and swine were successfully used 
for experimental cross-species transmission to non-human primates and domestic pigs 
(FEAGINS et al. 2008; HALBUR et al. 2001; MENG et al. 1998a; MENG et al. 1998b). 
Intravenously infected domestic pigs showed viremia and seroconversion, however, 
mostly without clinical signs (LEE et al. 2009; WILLIAMS et al. 2001). Rabbit HEV-3 
strains can be transmitted to domestic pigs, non-human primates and rabbits (CHENG 
et al. 2012; COSSABOOM et al. 2012; LIU et al. 2013). Experimental inoculation of 
non-human primates, swine and rabbits with human and swine HEV-4 strains has also 
been demonstrated (CHENG et al. 2012). Mongolian gerbils (Meriones unguiculatus) 
and [immunodeficient] house mice (Mus musculus) were used as small animal models 
demonstrating experimental cross-species transmissions of swine HEV-4 strains 
(DOCEUL et al. 2016). 
1.11 Geographical distribution 
HEVs and HEV-related viruses are distributed worldwide. However, the human-
pathogenic HEV genotypes (HEV-GTs) are differently distributed in geographically 
distinct regions of the world. HEV-1 mainly occurs in Eastern Asia (e.g. India, Pakistan, 
Russia and Japan) as well as in Northern and Eastern Africa (KAMAR et al. 2017) 
(Fig.6, yellow). HEV-2 has primarily been isolated in Mexico but can also be found in 
some areas of Africa (KAMAR et al. 2017) (Fig. 6, yellow). HEV-3 has been identified 
as the major GT in Europe and the USA, but was also detected in Australia, Africa, 
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Argentina and Japan (DE PAULA et al. 2013; KAMAR et al. 2017) (Fig. 6, orange). In 
contrast, HEV-4 is mainly confined to South-Eastern Asia with focus on China, Japan 
and Indonesia (KAMAR et al. 2017) (Fig. 6, blue and green). 
HEV and HEV-like viruses do have various animal reservoirs with “complex 
ecology and genetic diversity” worldwide (SRIDHAR et al. 2015) (Fig. 6). As already 
mentioned in chapter 1.9, this includes a wide range of different animal species. 
Domestic pig and wild boar are the main reservoirs of zoonotic HEV-3 and HEV-4 
(CARUSO et al. 2016; LAPA et al. 2015; MENG et al. 2009). These animals are widely 
distributed all over the world and the geographical distributions of HEV-3 and HEV-4 
in these animals are similar to that in humans (Fig. 6). HEV-5 and -6 have only been 
detected in single wild boars from Japan so far and HEV-7 seems to be mainly confined 
to the Middle East (LI et al. 2017; TAKAHASHI et al. 2014; TAKAHASHI et al. 2011; 
ZHOU et al. 2015). HEV-8 has so far only been detected in Bactrian camels (Camelus 
bactrianus) from a farm in China (WOO et al. 2016). A significant number of studies 
describes the detection of avian HEV and rat HEV in different countries of the world 
suggesting a worldwide distribution of these viruses (RYLL et al. 2017; ZHANG et al. 
2017; ZHANG et al. 2014). For the other HEV-like viruses, only scattered information 
is available on their geographical distribution. 
 
 
Adapted from KAMAR et al. 2017. 
Figure 6: Geographical distribution of HEVs. 
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1.12 Transmission pathways 
The distinct transmission pathways of human-pathogenic HEV are especially 
dependent on the GT of the virus (JOHNE et al. 2014). HEV-1 and HEV-2 are mainly 
transmitted via faecally contaminated drinking water (Fig. 7, yellow). For HEV-3, HEV-
4 and HEV-7, a foodborne transmission pathway has been shown, which is mainly 
based on consumption of raw milk and undercooked food prepared from infected 
animals (CHOI et al. 2013; LEE et al. 2016; RIVERO-JUAREZ et al. 2016) (Fig. 7, red 
and green/blue). In addition, transmission of HEV-3 and HEV-4 via contaminated blood 
products or organ transplantation has been shown (KAMAR et al. 2015; KAMAR et al. 
2014b; KAMAR et al. 2008). Several other transmission pathways, e.g. through 
environmental contamination with faeces (berries and shellfish) or direct contact to 
animals and humans, have been proposed, but often their evidence is proven scarcely 
(BRASSARD et al. 2012; CROSSAN et al. 2012; GAO et al. 2015; KHUROO et al. 
2009; MAUNULA et al. 2013; MESQUITA et al. 2016) (Fig. 7, dotted arrows). 
 
 
Adapted from SPAHR at al. 2018b. 
Figure 7: Transmission routes of human-pathogenic HEV-GTs. 
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1.13 Epidemiology 
In developing countries, HEV is responsible for more than 50% of acute viral 
hepatitis cases including over 50% cases in India, about 25% in Africa and 15–20% in 
the Eastern Orient (PURCELL and EMERSON 2008). In Africa, Asia and Latin 
America, human-pathogenic, zoonotic HEV-1 and HEV-2 are known to be endemic 
(OKAMOTO 2007; PUCRELL and EMERSON 2001). For Africa and Eastern Asia, 
approximately 20 million HEV infections are reported per year (REIN et al. 2012). One-
third of the world’s population – comprising more than two billion people – are living in 
areas highly endemic for HEV-1 and HEV-2 (WHO 2015). In these areas with poor 
sanitation conditions, e.g. China, India, Sudan, Chad and Uganda, large waterborne 
outbreaks and epidemics with thousands of cases were reported (AYE et al. 1992; 
MÉRENS et al. 2009; NAIK et al. 1992; TESHALE et al. 2010). Young to middle-aged 
male adults (15–40 years) seem to be afflicted predominantly (CHANDRA et al. 2008). 
Infections with HEV-1 are often associated with high mortality rates (15%–25%) in 
pregnant women (KHUROO et al. 1995). 
In industrialised countries, the human-pathogenic, zoonotic HEV-3 and HEV-4 
are predominant. HEV-3 is known to be endemic in European countries and is detected 
in 5–15% of the acute hepatitis cases (ADLHOCH et al. 2016; DALTON et al. 2008; 
LAPA et al. 2015). Out of these, most patients got infected, traveling to the above-
mentioned developing countries, preserving blood transfusions or regularly consuming 
pig meat (LAPA et al. 2015). However, the reported anti-HEV-antibody prevalence in 
European blood donors, up to 52% in France, gave evidence, that subclinical HEV 
infections are very common in industrialised countries (LAPA et al. 2015). It is 
estimated, that about 30% of the adult German population undergoes a mostly 
asymptomatic HEV infection within their lives (ANON. 2017). During the last years, the 
number of recorded autochthonous clinical hepatitis E cases has steeply been 
increased in many Western European countries (e.g. France, Germany, England and 
Wales), whereas in Northern and Southern European countries less cases were 
notified (ADLHOCH et al. 2016). As the management of the disease is subject to 
national policies, the notification, prevention and control is not implemented 
consistently in all countries. Figure 8 illustrates the development of the number of 
annually reported hepatitis E cases in Germany since 2001, when hepatitis E became 
a notifiable infectious disease (RKI 2019). The increase of recorded hepatitis cases 
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may be a result of the availability of novel diagnostic tools, enhanced awareness of 
human doctors or a raised public attention (ADLHOCH et al. 2016; PAVIO et al. 2010). 
 
 
Numbers adapted from RKI 2019. 
Figure 8: Number of recorded annual HE cases in Germany. 
1.14 Prevention 
In developing countries, prevention and control of human HEV infections with 
HEV-1 and HEV-2 is extremely important, as morbidity and mortality of the disease are 
relatively high. Improvement of hygiene and access to clean drinking water are the 
most effective ways to control HEV infections in these regions (PAVIO et al. 2010). 
Additionally, the consumption of insufficiently heated food, which may be contaminated 
during preparation, should be avoided (BfR FAQs 2016). 
In industrialised countries, where higher sanitation standards are common, the 
focus should be laid on the prevention of zoonotic HEV transmissions. 
Food-borne HEV infections with HEV-3 or HEV-4 are most common in 
industrialised countries. They can be prevented by complying with a good kitchen 
hygiene and cooking thoroughly meat products from pig, wild boar and deer (BfR FAQs 
2016). Heating over 70°C (degree Celsius) for at least 20 minutes inactivates the HEV 
(BARNAUD et al. 2012; JOHNE et al. 2016). 
People occupationally working with animals and animal samples, e.g. 
veterinarians, keepers, swine handlers, slaughterhouse workers and hunters, are at 
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higher risk of HEV-3 and HEV-4 infections (BfR FAQs 2016; PAVIO et al. 2017). This 
group of people should therefore be trained on hygienic measures while handling 
animals or animal products, e.g. for hunters to use gloves during evisceration of wild 
boars (SCHIELKE et al. 2015). Specific recommendation for veterinarians and animal 
keepers may be difficult as long as the distinct host range of HEV and HEV-like viruses 
and therefore the risk of infection by contact to a specific animal species are not known. 
Vaccination of the population, especially of groups of persons with higher risk 
for HEV infections, such as old, pregnant or immunocompromised persons with liver 
diseases, would be reasonable. However, a vaccination against HE is currently 
accredited in China only and has no concession for Europe (RKI 2015). 
As up to 50% of immunocompromised transplant patients come up with a 
chronic HEV infection after receiving repeated blood transfusions, blood donors and 
organ transplants should be routinely screened for HEV (ANON. 2017). In England, 
Ireland and the Netherlands HEV screening of donated blood has already been 
regulated in 2017 (ANON. 2017). To protect immunocompromised patients in Germany 
likewise, the screening of therapeutic blood products was very recently prescribed by 
the Paul-Ehrlich-Institut (PEI) (Deutsches Ärzteblatt 2018). Starting September, the 
30th 2019, blood products need to be proofed for HEV genome and declared HEV 
negative before application (Deutsches Ärzteblatt 2018). 
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2 Aims of the study 
The human-pathogenic zoonotic HEV-3, -4 and -7 are well-known to infect 
reservoir animals, such as domestic pig, wild boar, rabbit, deer and dromedary camel. 
In addition, other HEV-related viruses have been described in rodents, bats and fish, 
as well as in many other domestic and wildlife mammal and avian species. In most 
cases, the presence of HEV in these animals may be explained by “spillover 
infections”, but the available data are mostly rare. Non-human primates are known to 
be susceptible to a variety of human pathogens, including influenza, herpes and 
hepatitis B viruses. Using experimental infection trials, their susceptibility to HEV has 
been demonstrated. In contrast, little is known about natural HEV infections in non-
human primates. Also, the distinct role of other mammal species besides the well-
known reservoirs, in transmission of HEV to humans and other animals, is mostly not 
known so far. 
Against this background, the following major aims arose for this study. 
 
1. Review of the current knowledge about HEV infection in various animal 
species. The collation of published data on this topic should enable an 
overview on the occurrence of HEV infections in different animal species 
and taxons. 
2. Assessment of the incidence of natural HEV-infections in zoo-housed 
non-human primates. As these animals are known to be susceptible to 
human-pathogenic HEVs, the risk of virus transmission to humans may 
be high. 
3. The assessment of the prevalence of HEV in other mammal zoo animal 
species. Zoos are housing a huge species diversity within a small area, 
therefore offering excellent opportunities for research on zoonotic 
agents, which may give new insights into the general host range of HEV. 
4. Unravel potential transmission pathways of HEV in a zoo-setting. By in-
vestigating the HEV transmission between animals (different species, 
wild or from zoo) potential new starting points for prevention of HEV in-
fections in animals and humans may be identified. 
 
All animals should be tested for serological and molecular markers of HEV 
infection, using available detection methods for the analysis of sera and transudates. 
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Since rats have been suspected as HEV animal reservoir for several years, wild-living 
and feeder rats from two German zoos should be additionally investigated for the 
presence of rat HEV-RNA. Genomic and phylogenetic analysis of the detected animal 
HEV strains should clarify the transmission routes. 
The results of the study should help to assess the distribution of HEV and HEV-
related viruses among zoo-housed mammals and thus serve for decisions about 





3.1 Publication I 
 
Hepatitis E virus and related viruses in wild, domestic and zoo animals: A review 
 
Carina Spahr, Tobias Knauf-Witzens, Thomas W. Vahlenkamp, Rainer G. Ulrich and 
Reimar Johne 
 
Zoonoses and Public Health 2018 Feb., 65(1):11-29, Epub 2017 Sep. 24, 
<https://dx.doi.org/10.1111/zph.12405>. 
 
3.1.1 Summary of Publication I 
Hepatitis E is a human disease with zoonotic potential, which is increasingly 
recognised worldwide. Serologic and molecular evidence of HEV infection has been 
additionally described for many mammalian and avian species, suggesting the 
possibility of infection with HEV or HEV-like viruses in a wide range of animal species. 
However, the descriptions are mainly scattered into a large number of single 
publications, making general conclusions about the host range of HEV and the 
potential of distinct animal species for zoonotic HEV transmission difficult. Here, a large 
part of the available scientific literature on this topic has been reviewed and the findings 
were collated. 
According to the available literature, domestic pig, wild boar, rabbit and 
dromedary camel represent well-known animal reservoirs for human-pathogenic, 
zoonotic HEV-GTs HEV-3, HEV-4 and HEV-7. In addition, evidence for HEV infection 
has been described for about 50 other animal species originating from 19 taxonomic 
orders, including 19 avian species out of 10 taxonomic orders. However, in most of 
these animal species, HEV or HEV-related viruses have been detected sparsely and 
with low detection rates, which may be indicative for “spillover infections”. Many of the 
publications only describe the detection of HEV-reactive antibodies, what does not 
allow any conclusion on the involved virus strain and its zoonotic potential. In contrast 
to humans, animals generally seem to be infected asymptomatically with HEV. In 
addition to field investigations, experimental infections of several animal species have 
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been performed, which may also be used to clarify the epidemiology, transmission 
pathways and host range of HEV. 
In conclusion, many domestic, wildlife and zoo animal species have to be 
considered as potential carriers of HEV or HEV-related viruses in addition to the major 
reservoir animals (domestic pig and wild boar). Therefore, especially persons with 
occupational contact to these animals, e.g. breeders, hunters, slaughterhouse 
workers, animal keepers or veterinarians, are at higher risk for HEV infections. Natural 
HEV infections in animal species apart from the well-known virus reservoirs are clearly 
under investigated. Therefore, research on HEV infection in those animal species is 
needed to estimate the risk of zoonotic HEV transmission and to develop effective 
protection strategies for people in contact with the animals. 
3.1.2 Key messages of Publication I 
• HEV-3, -4 and -7 can be transmitted to humans from the reservoir 
animals domestic pig, wild boar, rabbit and dromedary camel 
• serological and molecular evidence of infection with HEV or HEV-like vi-
ruses is available for a wide range of other domestic, wildlife and zoo 
animal species 
• in contrast to reservoir animals, HEV is only sparsely detected in other 
animal species, which may indicate “spillover infections” 
• natural HEV infections in animals generally seem to be asymptomatic 
• experimental animal infections may contribute to elucidate transmission 
pathways and host range of HEV 
• further research on HEV in non-reservoir species is necessary for risk 
estimation of zoonotic HEV transmission and development of protection 
strategies for people in contact with the animals 
3.1.3 Own contribution to Publication I 
For this review, I performed intensive scientific literature research. I prepared all 
tables, as well as figure 1. 
I wrote the following chapters of the paper: the summary, the introduction, the 
chapters 3.1 and 3.2, 4.1.1 – 4.1.2, 4.2.1, the paragraphs 4, 5, 6, 9, 10, 11 of chapter 






























































3.2 Publication II 
 
Detection of HEV-specific antibodies in four non-human primate species, 
including great apes, from different zoos in Germany 
 
Carina Spahr, Tobias Knauf-Witzens, Lisa Dähnert, Martin Enders, Markus Müller, 
Reimar Johne and Rainer G. Ulrich 
 
Epidemiology and Infection 2018 Jan., 146(1):119-124, Epub 2017 Nov. 23, 
<https://dx.doi.org/10.1017/S0950268817002606>. 
 
3.2.1 Summary of Publication II 
The number of diagnosed cases of human infections with zoonotic HEV-GTs is 
currently increasing in many European countries. In order to unravel the HEV 
transmission pathways, contact to non-human primates should be considered, as 
these animals are known to be susceptible for a variety of other human pathogens like 
influenza, herpes and hepatitis B virus. It is also well-known that various non-human 
primate species can be experimentally infected with HEV, showing viremia and virus 
shedding, sometimes accompanied by clinical symptoms of hepatitis. However, little is 
known about natural HEV infections in non-human primates and the corresponding risk 
of zoonotic infections. 
In this study, 259 individual sera of clinically healthy non-human primates of 14 
species, from nine German zoos, were serologically and molecularly investigated for 
the presence of HEV. Using a double-antigen-sandwich ELISA (AXIOM® HEV-AB EIA, 
Bürstadt, Germany) and an IgG-ELISA (Mikrogen® recomWell HEV-IgG, Neuried, 
Germany), ten animals (3.9%) reacted positive in at least one assay. The HEV-specific 
antibodies were found in Western lowland gorillas (Gorilla gorilla gorilla), bonobos (Pan 
paniscus), lar gibbons (Hylobates lar) and drills (Mandrillus leucophaeus). No history 
of clinical symptoms of hepatitis was recorded in these animals. Testing for anti-HEV-
IgM antibodies by ELISA (Mikrogen® recomWell HEV-IgM, Neuried, Germany) and for 
viral RNA by RT-qPCR resulted in negative results. 
It can be concluded that non-human primates in zoos can get infected with HEV 
or HEV-related viruses, without showing obvious clinical signs of hepatitis.  Compared 
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to three other studies, the non-human primates analysed in this study showed 
surprisingly low detection rates of markers of HEV infection. The source of infection 
with HEV or HEV-related viruses for the primates is unknown but may be through 
contact with excretions or contaminated food/water. Despite the low detection rates 
observed, the possibility of virus transmissions from non-human primates to humans 
in contact with them should be considered. 
3.2.2 Key messages of Publication II 
• evidence of natural infection with HEV or HEV-related viruses of three 
great ape species and one ape species in European zoos: 
- bonobo (Pan paniscus) 
- gorilla (Gorilla gorilla gorilla) 
- lar gibbon (Hylobates lar) 
- drill (Mandrillus leucophaeus) 
• 3.9% (10/259) of the investigated animals were anti-HEV-IgG positive 
• no history of clinical signs of hepatitis in the seropositive animals 
• negative PCR and anti-HEV-IgM results indicate absence of acute HEV 
infections 
• comparatively low HEV seroprevalences in non-human primates 
• nevertheless, the possibility of virus transmissions from non-human 
primates to humans in contact with them should be considered 
3.2.3 Own contribution to Publication II 
I was responsible for the serum collection, including own sampling, request for 
samples from the participating zoos and shipment of samples. Additionally, I gathered 
information on the physical health status of each non-human primate, using ZIMS 
Species 360 and databases of the zoos. I performed the Axiom® HEV-Ab EIA, RNA 
isolation and RT-qPCR. I analysed the data and wrote the following parts of the paper: 























3.3 Publication III 
 
Serological evidence of hepatitis E virus infection in zoo animals and 
identification of a rodent-borne strain in a Syrian brown bear 
 
Carina Spahr, René Ryll, Tobias Knauf-Witzens, Thomas W. Vahlenkamp, Rainer G. 
Ulrich and Reimar Johne 
 
Veterinary Microbiology 2017 Dec., 212:87-92, Epub 2017 Nov. 9, 
<https://dx.doi.org/10.1016/j.vetmic.2017.11.005>. 
 
3.3.1 Summary of Publication III 
Hepatitis E is a human disease, which can be zoonotically transmitted from 
animals. HEV infections have been repeatedly described with high detection rates in 
domestic pig and wild boar, representing the major reservoir animals for HEV. 
Furthermore, HEV and HEV-related viruses have been detected in a variety of other 
mammal and avian species. However, the occurrence of natural HEV infections in zoo 
animals has only scarcely been investigated so far. 
In this study, 244 individual sera of 66 zoo-housed mammal species from three 
zoos in Germany were serologically investigated. A double antigen sandwich ELISA, 
based on the HEV-1 capsid protein, was used for species-independent detection of 
HEV-specific antibodies. Molecular analysis for detection of HEV- or rat HEV-RNA was 
performed using three different PCR protocols. As a result, 16 animal species were 
tested positive for HEV-specific antibodies, with the highest detection rates in suids 
(33.3%) and carnivores (27.0%). RNA of human-pathogenic HEV-1 to HEV-4 was not 
detected in any of the samples. However, rat HEV-RNA was detected in the serum of 
a clinically healthy female Syrian brown bear (Ursus arctos syriacus). Analysis of 
subsequent serum samples confirmed a HEV seroconversion in this animal. Closely 
related rat HEV-sequences were found in pest rats (Rattus norvegicus) from the same 
location, whereas molecular and serologic investigations of feeder rats (Rattus 
norvegicus forma domestica) resulted in negative results. 
In conclusion, evidence for infection with HEV or HEV-related viruses was 
shown for many mammalian zoo animal species. Therefore, the possibility of virus 
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transmissions to other animals and humans has to be considered. Besides the 
expected high seroprevalence in suids, the high detection rate in carnivores warrants 
further investigations on their possible function as reservoir animals. The detection of 
rat HEV in the Syrian brown bear suggests a higher zoonotic potential of this virus as 
expected in earlier studies. A “spillover infection” from pest rats living in the zoo is most 
likely. Further investigations on consequences of HEV and rat HEV infections for zoo 
animals and humans should be initiated. 
3.3.2 Key messages of Publication III 
• evidence of natural infection with HEV or HEV-related viruses in 16 zoo 
animal species from European zoos 
• highest seroprevalences were found in suids (33.3%) and carnivores 
(27.0%) 
• detection of rat HEV-RNA in the serum of a Syrian brown bear, that also 
showed seroconversion 
• closely related rat HEV-strains were found in pest rats from the same 
location indicating a “spillover infection” 
• many zoo animals have to be considered susceptible to HEV or HEV-
related viruses 
• the role of carnivores as potential additional reservoir animals for HEV 
should be investigated in future 
3.3.3 Own contribution to Publication III 
I was responsible for the serum and rat collection, including own sampling, 
request for samples at the participating zoos and shipment of samples. I implemented 
the dissection of rats and participated in the dissection of died zoo animals and 
sampling of livers at the CVUA Fellbach. Additionally, I gathered information on the 
physical health status of the female Syrian brown bear using databases of the zoo. I 
performed the Axiom® HEV-Ab EIA, RNA isolation from sera and liver samples, as 
well as PCR analyses. I analysed the data and wrote the following chapters of the 
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4 General discussion 
4.1 HEV infections in various animal species 
Since more than thirty years, attempts have been made to ascertain the animals 
that are susceptible to HEV infections – either by natural infection, or by experimental 
infection trials. The results of the studies presented in this thesis further lead to an 
increase of the number of animal species, which showed serological evidence of HEV 
infection. Taken together these data with those published by others, HEV and HEV-
like viruses or antibodies specific against them have been detected in more than 100 
animal species, including 19 avian species (Tab. 2) out of 10 taxonomic orders, about 
80 mammal species (Tab. 3 and Tab. 4) out of 9 taxonomic orders, as well as fish so 
far. The susceptible species include various wild, domestic and zoo animal species. 
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+, positive; n.d., not determined; *, laboratory animals. 
Table 2: Natural HEV infections in birds. 
Domestic pig (HEV-3 / HEV-4), wild boar (HEV-3 / HEV-4), rabbit (HEV-3), deer 
(HEV-3) and dromedary camel (HEV-7) are well known to serve as reservoir animals 
that can be infected with the human-pathogenic HEV types (HUANG et al. 2016; LI et 
al. 2005; RUTJES et al. 2010; SRIDHAR et al. 2017). However, infections with zoonotic 
HEV-3 and HEV-4 are not restricted to these reservoir animals and humans only 
(PAVIO et al. 2015; YAN et al. 2016). They have been reported for several avian and 
mammal species including ungulates (cow, goat), non-human primates (rhesus 
macaque, chimpanzee), rodents, predators, wales and avian species (LI et al. 2015; 
MONTALVO VILLALBA et al. 2017; YAMAMOTO et al. 2012; ZHANG et al. 2008a). 
Especially in low income countries, many people are housing several kinds of free-
ranging livestock to nourish their families. Therefore, different livestock species could 
come in close contact to each other or to wild animals. In these countries, for traditional 
reasons, intimate human animal contact and the consumption of raw milk and raw meat 
together with only basal hygienic standards may enforce the transmission of zoonotic 
HEV types to humans (HUANG et al. 2016; LEE et al. 2016; LONG et al. 2017). 
Additional HEVs have been described in further reservoir animals: mongoose 
(HEV-3), moose (moose HEV), wild boar (HEV-5 and HEV-6), Bactrian camel (HEV-
8), rodents (HEV-C1), red fox, ferret and mink (all HEV-C2), lagomorphs (rabbit HEV), 
bat (bat HEV), birds (avian HEV) and fish (fish HEV) (SPAHR et al. 2018b). New and 
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undefined HEVs have been reported in chimpanzee, falcons, and little egret (Egretta 
garzetta) (REUTER et al. 2016a,b; ZHOU et al. 2014). 
In most animal species, HEV is detected sparsely. On the one hand, this may 
be due to low sample numbers investigated for each of these species. On the other 
hand, “spillover infections” from reservoir species to host species resulting in only a 
few successful virus transmissions seem to be possible. In other animal species, HEV 
infections are more often described and/or with higher prevalence. Based on the data 
from this thesis and other published results, predators and hoofed animals show higher 
prevalences than other groups of animals and therefore seem to be predisposed for 
HEV infections (DÄHNERT et al. 2018; SPAHR et al. 2018a; SPAHR et al. 2017). The 
next chapters should give a more detailed overview and discussion on the prevalences 
of HEV infections in different groups of animal species. 
4.2 Prevalence of natural HEV infections in non-human primates 
Reports about natural HEV-infections in non-human primates are scarcely 
available, so far (Tab. 3). Besides, the detection rates of anti-HEV-ab are varying quite 
a lot between the different species and different studies (SPAHR et al. 2018a). For 
example, the reported IgG-seroprevalences in monkeys from India and China ranged 
from 2% (1/50) in langur monkeys (Semnopithecus entellus) up to 35.87% (33/92) or 
36.7% (36/98) in rhesus macaques from a breeding facility in Japan (ARANKALLE et 
al. 1994; HUANG et al. 2011). The IgG-seroprevalence in bonnet macaques was 
reported to be 19.1% (9/47) (ARANKALLE et al. 1994). Anti-HEV-IgM-ab were 
reported for 3/33 rhesus macaques from China and a small number of rhesus 
macaques in a breeding facility at the Primate Research Institute of the University of 
Kyoto, Japan, where seroconversion after HEV-3 infection was observed (HUANG et 
al. 2011; YAMAMOTO et al. 2012). The highest IgG-seroprevalence of 78.5% (96/121) 
was reported for rhesus macaques (YAMAMOTO et al. 2012). In contrast, only one out 
of nine lower primate species (1.2%, 1/86), showed HEV-reactive antibodies in the 
study presented in this thesis (SPAHR et al. 2018a). 
To date, the investigation of lower non-human primates is standing to the forth, 
as certain species are housed in laboratories and are therefore easily available for 
sampling. To widen the range of species, we investigated 259 zoo-housed individuals, 
belonging to 15 species, for the presence of anti-HEV-ab, which also included 172 
great ape samples (Hominidae) (SPAHR et al. 2018a). As a result, 3.9% (10/259) of 
the animals (7 gorillas, 1 bonobo, 1 lar gibbon, and 1 drill) were anti-HEV-IgG-ab 
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positive. Surprisingly, most seropositive animals were gorillas (15.2%, 7/46), followed 
by lar gibbons (9.1%, 1/11) and bonobos (4%, 1/25). There is only one additional report 
about natural HEV infection in chimpanzees from a Chinese zoo (ZHOU et al. 2014). 
A novel HEV-RNA was detected in the faeces of 7/24 (29.2%) of these chimpanzees 
(ZHOU et al. 2014). In contrast, anti-HEV-ab could not be detected in 70 chimpanzees’ 
sera from European zoos in the study described in this thesis (SPAHR et al. 2018a). 
Taken together, the study presented in this thesis was able to show that non-
human primates including great apes can show markers of HEV infection. However, 
the determined antibody prevalences were generally lower as compared to most other 
published studies. In addition, it showed a higher proportion of anti-HEV-IgG positive 
great apes (3.5%, 6/172) compared to the very lower prevalence in non-human 
primates (1.1%, 1/87). As the samples from the different studies originate from different 
areas, general differences due to the geographical origin of the samples may explain 
these findings. In addition, different assays have been used for analysis, which 
therefore cannot be compared directly. The IgG assay used in the study described in 
this thesis is originally adapted for human sera and may therefore be more sensitive 
for the closely related great apes than for lower non-human primate species. An 
additional problem in studying non-human primates is, that blood samples for HEV 
monitoring are mostly not available spontaneously. Therefore, many zoos established 
their own serum banks, storing sera from non-human primates, collected during 
immobilisations for different purposes. Long-term storage and frequent freeze-thaw 
cycles may have led to a decrease of HEV-ab amounts in the investigated sera. 
It can be concluded that non-human primates including great apes seem to be 
susceptible to HEV infections. However, the determined prevalences were low thus 
arguing against a role of these animal species as a reservoir for HEV. It cannot be 
decided if HEV infections lead to clinical disease in these species or not, because at 
the time of sampling, all investigated animals were HEV-RNA- and anti-HEV-IgM-
negative, indicating that no ongoing infections could be observed in this study. 
However, as no history of hepatitis was recorded in these animals, the presence of 
subclinical infections is likely. 
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+, positive; n.d., not determined; 0%, negative; %, positive in %; *, natural infection in laboratory monkeys. 
Table 3: HEV infections in non-human primates. 
4.3 Prevalence of natural HEV infections in other zoo-housed mammals 
In general, reports about HEV infections in zoo-housed animals (birds and 
mammals) are scarcely available so far (LI et al. 2015; ZHANG et al. 2008a; ZHOU et 
al. 2014). To better assess the role of zoo-housed mammals as reservoir or host 
species, we investigated 244 serum samples from 66 clinically healthy mammal 
species in the study described in this thesis (SPAHR et al. 2017).  As a result, anti-
HEV-specific-ab were found in the sera of 16 mammal species from European zoos. 
Besides the well-known reservoir species, swine (33.3%) and deer (8%), two species 
of goat and donkey, one antelope species and five carnivore species were anti-HEV-
IgG-positive (Tab. 4, zoo animals). 
Particularly, the high seroprevalence in carnivores (27.0%) was remarkable, 
thus justifying further investigations in this animal group. In summary, five out of seven 
analysed carnivore species were tested seropositive, including maned wolf, California 
sea lion (Zalophus californianus), Syrian brown bear (Ursus arctos syriacus), Persian 
leopard (Panthera pardus saxicolor) and snow leopard (Unica unica). Interestingly, rat 
HEV-RNA was detected in the serum of a female Syrian brown bear and 
seroconversion was demonstrated in the same animal (SPAHR et al. 2017). 
Conclusively, wild-ranging pest rats may have been the source of HEV infection for 
this animal. 
By summarising the findings of the study presented in this thesis and other 
published data, infections with HEV-3, HEV-4, HEV-C2 or rat HEV are reported for the 
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following carnivore species: Asiatic black bear (Ursus thibetanus), cat (Felis catus 
silvestris), California sea lion, clouded leopard (Neofelis nebulosa), dog, ferret (Mustela 
putorius), maned wolf (Chrysocyon brachyurus), mink (Mustela lutreola), mongoose 
(Herpestes javanicus), Persian leopard, raccoon (Procyon lotor), raccoon dog 
(Nyctereutes procyonoides), red fox, snow leopard and Syrian brown bear (Tab. 4). 
HEV infections in cats and dogs have been described before (LIANG et al. 2014; LIU 
et al. 2009; MOCHIZUKI et al. 2006). ARANKALLE et al. (2001) provided an indication 
that carnivores living in HEV-endemic areas are more susceptible to HEV infections. 
He ascertained an anti-HEV-IgG seroprevalence of 22.7% (10/44) in dogs from India 
(ARANKALLE et al. 2001). The high seroprevalence may be explained by the feeding 
behaviour of the straying dogs and the bad hygiene conditions in India. ZHANG et al. 
(2008a) first detected mammalian HEV-4-RNA in one clouded leopard and one Asiatic 
black bear. All animals were clinically healthy. The findings were explained by “spillover 
infection” from other animal species in this zoo, which were also tested positive in this 
study (ZHANG et al. 2008a). 
It can be concluded, that the available data show, that many mammalian 
species are susceptible to HEV infections. Most of these species show only low 
prevalences, which are suggestive for “spillover infections”. Porcine species clearly 
show high prevalences in congruence with their role as reservoir animals. Remarkably, 
carnivore species turn out more and more to also show higher seroprevalences. Very 
recently, DÄHNERT et al. (2018) reported high seroprevalences in raccoons (53.8%, 
43/80), raccoon dogs (34.3%, 25/73), pet dogs (56.6%, 47/83) and pet cats (32.3% 
(21/65) from Brandenburg, Germany. These recent findings underline the notion of 
carnivores being natural HEV hosts (DÄHNERT et al. 2018; SPAHR et al. 2017). The 
reasons for the indicated high seroprevalences are not known so far. Infection by 
ingestion of infected prey animals may be speculated. However, as mostly only (cross-
reacting) antibodies have been demonstrated, the HEV types responsible for the 
antibody production are not known in most cases. In addition, productive infection and 
transmission of virus needs to be demonstrated in future studies in order to clarify the 
role of carnivores in HEV epidemiology. 
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+, positive; -, negative; n.d., not determined; *, laboratory animals. This table does not include all references  
to the individual animal species. There are numerous publications on pigs in particular (PAVIO et al. 2017). 
Table 4: Natural HEV infections in mammals. 
4.4 Transmission pathways of HEV in a zoo-setting 
In a zoo-setting, different animal species live together in a comparatively 
confined space and wild animals mostly could come in contact with these. Therefore, 
various transmission pathways of HEV seem to be possible. Some of these 
transmission pathways are illustrated in Figure 9, using the example of the Syrian 
brown bear. In general, HEV transmission via direct (bold arrows) or indirect (dotted 
arrows) contact is delineated. 
Direct contact between reservoir species (e.g. swine, wild boar, rabbit, rat, fox, 
dromedary, human) and other species (e.g. brown bear, carnivores, non-human 
primates) can lead to transmissions of HEV. This transmission pathway seems to be 
very likely in a zoo-setting as contacts between neighboured animals and with wild 
animals (e.g. rats) cannot be excluded. As an evidence, we detected rat HEV-RNA in 
the Syrian brown bear and demonstrated seroconversion in the same animal (SPAHR 
et al. 2017). The additional PCR-screening of 73 free-ranging Norway rats from two 
German zoos (including the zoo, housing the Syrian brown bear) resulted in the 
detection of eight rat HEV-positive animals (11%). Sequence analysis revealed that all 
detected rat HEV sequences were closely related to each other and showed a high 
nucleotide sequence identity (94.6% – 97.8%) to the isolate from the bear. These 
results indicate that “spillover infection” from free-ranging pest rats (delineated in 
green), representing a known reservoir for rat HEV, is most likely in the case of the 
Syrian brown bear (SPAHR et al. 2017). Although pest control programmes are 
enforced, free-ranging pest rats or rabbits may enter outdoor enclosures from 
carnivores, that are able to catch and gorge them. 
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Additional transmission pathways may be theoretically possible within zoo 
settings. Direct transmission of HEV between fellow species (delineated in blue), e.g. 
via social behaviour or mating, seems to be one more possible pathway for HEV 
infection. On the basis of preservation measures for many zoo animal species, the 
pan-European and worldwide exchange of these animals between zoos involves the 
danger of HEV transmissions. Infected animals, that were captured in the wild, 
transferred into a zoo and socialised with the zoo population, portray a possible risk for 
HEV infection in the housed animal stock (SPAHR et al. 2018a). However, also the 
shipment of zoo-borne animal stock reveals a potential risk of HEV transmission 
between fellow species. 
Zoo animals, especially pigs and carnivores, may circulate and amplify the virus 
leading to a high virus release to the environment, which can thereafter be transmitted 
to other animal species by oronasal contact (SPAHR et al. 2017). Consumption of 
contaminated water resources may lead to HEV infections in animals, too (SPAHR et 
al. 2018b). Even feed (e.g. hay, straw, vegetables, fruits, grains, pelleted feed) could 
be contaminated with HEV by excretions of pest animals, dependent on storage 
conditions. Feeder animals (e.g. rat, rabbit), zoo animals killed for feeding purposes 
(e.g. deer, swine, camel, dromedary, antelopes, goat, sheep) or contaminated meat 
may also be a source of HEV infection in carnivorous zoo animal species. 
Staff may also play a part contributing to indirect HEV transmission. If keepers 
are changing between animal enclosures or using the very same dunghill for disposing 
excretions of swine, carnivores and non-human primates, HEV transmission via 
contaminated material (e.g. shoes, wheel barrow, bugs, pitchfork, dustpan, brush, 
rake, vehicles) seems to be possible and may even portray a risk for the transmission 
of zoonotic HEVs from reservoir species (delineated in red) as swine, wild boar, rabbit, 
deer, mongoose or dromedary camel. 
In conclusion, there are manifold possibilities for transmission of HEV and HEV-
related viruses in a zoo-like setting. Attempts should be done to minimize the degree 
of virus transmission by applying several hygienic measures and control of wild animals 
in order to prevent infections of zoo animals and – in specific situations – also of the 
staff. 
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Figure 9: Possible transmission pathways of HEV in a zoo-setting. 
4.5 Risk of virus transmission from zoo animals to humans 
Non-human primates, especially great apes, are closely related to human 
beings and are known to be susceptible to diverse human pathogens, including HEV 
(SPAHR et al. 2018a). Due to medical training and treatment, non-human primates 
kept in zoos are usually in close contact with their keepers. Although hygiene standards 
in the holding institutions are high and the staff is encouraged to use face masks and 
gloves, direct contact to infected animals cannot be ruled out as possible way of vertical 
HEV transmission (BUITENDIJK et al. 2014; FICKENSCHER and FLECKENSTEIN 
2001; MEALS et al. 2016). The relatively low seroprevalence rates in our field study 
with 3.9% (10/259) seropositivity in non-human primates argue against a high risk of 
HEV transmission to humans. Additionally, there was no direct evidence for an 
infection with zoonotic HEV-1 to HEV-4 in the animals in the study presented in this 
thesis as only antibodies were detected (SPAHR et al. 2018a). 
However, YAMAMOTO et al. (2012) reported on an HEV outbreak in a 
Japanese monkey breeding facility were anti-HEV-3-IgG-seroprevalences from the 
staff simultaneously increased with the decrease of anti-HEV-3-IgM-ab and anti-HEV-
3-IgG-ab from the animals. Anti-HEV-3-IgG-seroprevalence in humans was 6.9% 
(2007), 9.7% (2008) and 11.8% (2009) in comparison to the anti-HEV-3-IgM-
seroprevalence in the animals with 1.1% (2007) and 0% (2008, 2009). The authors 
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assumed, that the staff got infected by direct contact to the monkeys or their blood or 
excretions (YAMAMOTO et al. 2012). 
ZHANG et al. (2008a) detected mammalian HEV-4-RNA in carnivores, deer and 
birds from a Chinese zoo-like location. In parallel, seven workers including a 
veterinarian and six feeders, were tested for anti-HEV-ab (IgM and IgG) plus HEV-
RNA (ZHANG et al. 2008a). All sera were HEV-RNA negative, but one person was 
positive for IgM, 3 persons for IgG and another was positive for both IgM and IgG 
(ZHANG et al. 2008a). 
Infection of humans via direct contact to animals (e.g. wild boar), faeces, blood 
or aerosols from animals has previously been discussed as a possible transmission 
route (DREMSEK et al. 2013; DREMSEK et al. 2012). It is known, that people 
occupationally working with animals and animal products are at higher risk for HEV 
infections with zoonotic HEV-3 and HEV-4 (BfR FAQs 2016; PAVIO et al. 2017). In 
principle, staff working in a zoo-like setting has also to be considered to be exposed to 
HEV by contact to the animals and to their excretions. However, as the HEV 
prevalences seem to be lower in most zoo animal species as compared to domestic 
pigs, the risk of virus transmission has to be considered to be lower in general. In line 
with this, zoo animals of porcine species origin and carnivores should be considered 
of higher risk for HEV transmission. 
Another factor limiting the assessment of the virus transmission to humans is 
the missing information on the specific virus types present in the zoo animals. In fact, 
only rat HEV was convincingly demonstrated in the study presented in this thesis. 
Generally, the zoonotic potential of rat HEV for transmission to humans has been 
considered low for a long time due to its divergent phylogenetic relationship to the other 
human-pathogenic HEVs (JOHNE et al. 2014). However, very recently, a rat HEV 
infection leading to chronic hepatitis has been described in an immunosuppressed 
human patient from Hong Kong (SRIDHAR et al. 2018). Further studies are necessary 
to clarify if this represents only a single exception, or if rat HEV indeed represents a 
human pathogen. 
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5 Conclusion and perspectives 
Our results significantly increase the number of animal species with indications 
of natural infections with HEV or HEV-related viruses. In particular, predators and 
hoofed animals seem to be predisposed for HEV infections. 
Zoo-housed non-human primates, particularly gorillas, showed serological 
markers of HEV infection, although with low prevalences. This leads to the assumption, 
that non-human primates are accidental hosts, but not important reservoir animals for 
HEV. To clarify the variation in seroprevalences between bonobos, chimpanzees, 
orangutans and gorillas, human ELISAs should be assessed for their specificity and 
sensitivity in detecting anti-HEV-ab in sera from non-human primates. 
Based on the study presented in this thesis, the range of susceptible zoo-
housed mammals, which show HEV seroprevalences, contains canids, felids, otariids, 
ursids, suids, bovids, cervids and equines. Whereas the high seroprevalences were 
expected for the porcine-related species, they were somewhat surprising for the 
carnivores. However, only a few studies have analysed HEV-infections in carnivores 
so far. The high prevalences may indicate a role as reservoirs or transmitters for these 
animal species. However, especially in the carnivores, the high seroprevalences may 
also be explained by a reaction on frequent ingestions of HEV-infected animals, which 
not necessarily has to result in high virus replication and excretion. The identified rat 
HEV infection in the Syrian brown bear may reflect such an infection gained by 
ingestion of infected wild rats. Further studies should attempt to elucidate the HEV 
infection of carnivores in more detail including studies on the route of infection, the 
involved HEV types and the amount of excreted virus. 
The absence of the detection of any human-pathogenic HEV-GT-RNA in the 
animals investigated in the study presented in this thesis may suggest, that 
anthropozoonotic transmission is unlikely. However, as HEV-specific antibodies are 
known to cross-react between human-pathogenic and HEV-like viruses, the virus types 
originally infecting the animals are not known. People occupationally working with 
animals have been shown in several studies to be at higher risk for zoonotic HEV 
infections. Therefore, staff working in a zoo-like setting has also to be considered to 
be exposed to HEV by contact to the animals and to their excretions. However, the low 
HEV prevalences in most zoo animal species may indicate a lower risk for zoo workers 
as compared to workers in contact with domestic pigs. Future studies comparing the 
seroprevalences of zoo workers with that of non-exposed persons will be necessary to 
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clarify the risk of HEV transmission in zoo-like locations. In addition, in light of the 
recent publication of a human rat HEV infection, the zoonotic potential of rat HEV 
should be investigated in more detail as this virus was detected by us in a zoo animal. 
Future HEV monitoring in carnivores, hoof stock and non-human primates is 
highly recommended to prove their role as potential reservoirs for HEV or HEV-related 
viruses, to evaluate potential differences in the susceptibility of certain animal species, 
to identify potential transmission routes and to assess possible veterinary and public 
health risk consequences. This should also include known reservoir species living in 
zoos, such as pigs, deer, rabbits and rats, in order to identify the virus sources. To 
prevent virus transmissions, the control of pest animals and feeder animals used for 
carnivores and improved feeding hygiene should be considered in zoos. Additionally, 
specific material for cleaning work should be assigned separately to each species to 
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Hepatitis E is a worldwide distributed disease, which is caused by the hepatitis E 
virus (HEV). In addition to humans, domestic pigs, wild boars, rabbits and dromedaries 
can be subclinically infected as reservoir animals with the zoonotic HEV genotypes 3, 
4 and 7. In addition, HEV and HEV-like viruses have been described sporadically in 
other mammals, as well as in birds and fish, although their distinct role as reservoirs 
or carriers of the virus is still unclear. 
Aims 
The aim of the study was therefore to analyse in more detail the importance of 
different mammalian species, which do not belong to the known HEV reservoirs, for 
the epidemiology of HEV infections, thus enabling a better assessment of the risk of 
virus transmission by these animal species. 
Material and Methods 
Fourteen non-human primate species and 66 other mammal species, as well as 
Norway rats (Rattus norvegicus) and feeder rats (Rattus norvegicus forma domestica) 
from German zoos were selected for the investigations. In total 259 individual non-
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human primate sera and 244 individual mammalian sera of clinically healthy zoo 
animals were analysed for the presence of HEV-specific antibodies (ab) using a 
species-independent double-antigen sandwich ELISA. The non-human primate sera 
were additionally examined using a commercial human ELISA. Real-time reverse-
transcription (RT)-PCR, nested broad-spectrum RT-PCR and a rat HEV-specific RT-
PCR were used to detect the HEV genome in sera of mammals and rat liver samples. 
A commercial and an in-house method were used for the DNA sequencing. 
Results 
HEV-specific ab were detected in 3.9% (10/259) of the non-human primate sera (4 
species) and 11.5% (28/244) of the mammalian sera (16 species). The highest 
detection rates were recorded with 33.3% (9/27) in porcines and with 27.0% (10/37) in 
carnivores. HEV-RNA was detected in a clinically healthy female Syrian brown bear 
(Ursus arctos syriacus) and in 8 of the investigated Norway rats. Sequence analysis 
identified the virus as rat HEV; the viruses from the bear and the free-ranging rats from 
the same zoo showed a high nucleotide sequence identity (94.6%–97.8%). Because 
of the small number of samples due to the small populations within the individual zoos, 
further statistical evaluations were not carried out. 
Conclusions 
The results show that non-human primates in zoos may be infected with HEV or 
HEV-like viruses; however, the low ab detection rates together with the negative 
genome detection argue against a high risk of virus transmission to humans. The study 
in other zoo-housed mammalian species was able to significantly increase the number 
of animal species with indications of HEV infections. In most animal species, only rare 
evidence and low detection rates were available, which can best be explained by 
“spillover-infections”. In addition to the expected high detection rate in porcine species, 
the high percentage of HEV antibody-positive carnivores is remarkable. Their role as 
possible HEV reservoir animals should therefore be clarified in further investigations. 
The detection of rat HEV in the serum of the bear and its high nucleotide sequence 
identity with the HEVs of the pest rodents provides first evidence of transmission of 
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Hepatitis E ist eine durch das Hepatitis E-Virus (HEV) verursachte, weltweit 
verbreitete Erkrankung. Neben dem Menschen können Hausschwein, Wildschwein, 
Kaninchen und Dromedar als Reservoirtiere subklinisch mit den zoonotischen HEV-
Genotypen 3, 4 und 7 infiziert werden. Darüber hinaus wurden HEV und HEV-ähnliche 
Viren vereinzelt bei weiteren Säugetieren, sowie Vögeln und Fischen beschrieben, 
wobei deren genaue Rolle als Reservoir oder Überträger des Virus bislang unklar ist. 
Ziele 
Ziel der Arbeit war es deshalb, die Bedeutung verschiedener Säugetierarten, die 
nicht zu den bekannten HEV-Reservoiren gehören, für die Epidemiologie der HEV-
Infektionen besser zu erfassen und dadurch das Risiko einer Virusübertragung durch 
diese Tierarten besser abzuschätzen. 
Material und Methoden 
Vierzehn Affenarten und 66 weitere Säugetierarten, sowie Wanderratten (Rattus 
norvegicus) und Futterratten (Rattus norvegicus forma domestica) aus deutschen 
Zoos wurden für die Untersuchungen ausgewählt. Insgesamt wurden 259 individuelle 
7 Zusammenfassung 
 78 
Affenseren und 244 individuelle Säugerseren klinisch gesunder Zootiere mittels eines 
Spezies-unabhängigen Doppel-Antigen-Sandwich-ELISAs auf das Vorhandensein 
von HEV-spezifischen Antikörpern (AK) untersucht. Die Affenseren wurden zusätzlich 
mittels eines kommerziellen humanen ELISAs untersucht. Real-time reverse-
transcription (RT)-PCR, nested broad-spectrum RT-PCR sowie eine Ratten-HEV-
spezifische RT-PCR wurden für den HEV-Genomnachweis in Seren der Säuger und 
in Ratten-Lebern verwendet. Für die DNA-Sequenzierungen wurden eine 
kommerzielle und eine In-house-Methode verwendet. 
Ergebnisse 
In 3,9% (10/259) der Affenseren (4 Arten) und 11,5% (28/244) der Säugerseren (16 
Arten) wurden HEV-spezifische AK nachgewiesen. Die höchsten Nachweisraten 
wurden mit 33,3% (9/27) in Schweineartigen und 27,0% (10/37) in Fleischfressern 
ermittelt. HEV-RNA wurde in einer klinisch gesunden Syrischen Braunbärin (Ursus 
arctos syriacus), sowie in 8 der untersuchten Wanderratten nachgewiesen. Die 
Sequenzanalyse identifizierte das Virus als Ratten-HEV; die Viren aus der Bärin und 
aus den wildlebenden Ratten desselben Zoos zeigten eine hohe Nukleotidsequenz-
Identität (94,6%–97,8%). Weitergehende statistische Auswertungen wurden wegen 
der geringen Probenzahlen aufgrund der kleinen Populationen innerhalb der einzelnen 
Zoos nicht durchgeführt. 
Schlussfolgerungen 
Die Ergebnisse zeigen, dass Affen in Zoos mit HEV oder HEV-ähnlichen Viren 
infiziert sein können, jedoch sprechen die geringen AK-Nachweisraten zusammen mit 
den negativen Genomnachweisen gegen ein hohes Übertragungsrisiko auf den 
Menschen. Die Studie an anderen Säugetierarten in Zoos konnte die Zahl der 
Tierarten mit Hinweisen auf HEV-Infektionen deutlich erhöhen. Bei den meisten 
Tierarten lagen nur seltene Nachweise und niedrige Detektionsraten vor, die am 
besten durch „Spillover-Infektionen“ erklärt werden können. Neben der erwarteten 
hohen Nachweisrate bei Schweineartigen ist der hohe Prozentsatz an HEV AK-
positiven Fleischfressern bemerkenswert, weshalb deren Rolle als mögliche HEV-
Reservoirtiere in weiteren Untersuchungen geklärt werden sollte. Der Ratten-HEV-
Nachweis im Serum der Bärin, sowie dessen hohe Nukleotidsequenz-Identität zu den 
HEVs der Schadnager geben erstmals Hinweise auf eine Übertragung dieser Virusart 
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List of animals investigated in the study 
 
Family Animal Species Scientific name 
 
Atelidae 
 Black howler monkey Alouatta caraya 
 White-fronted spider monkey Ateles hybridus 
Bovidae 
 Addax Addax nasomaculatus 
 African buffalo Syncerus caffer nanus 
 Alpine ibex Capra ibex 
 Anoa Bubalus depressicornis 
 Barbary sheep Ammotragus lervia 
 Bezoar goat Capra hircus domestic bezoar 
 Bongo Tragelaphus eurycercus 
 Common waterbuck Kobus ellipsiprymnus 
 Congo dwarf goat Capra hircus domestic congo 
dwarf 
 Domestic cattle  
(Hinterwald cow) 
Bos taurus Taurus hinterwald 
 Domestic cattle  
(Limpurger cow) 
Bos taurus Taurus limpurger 
 Domestic goat  
(Damara goat) 
Capra hircus domestic damara 
 Domestic sheep  
(Cameroon sheep) 
Ovis aries aries cameroon 
 Domestic sheep  
(Skudde sheep) 
Ovis aries aries skudde 
 Dorcas gazelle Gazella dorcas 
 European wisent Bison bonasus bonasus 
 Greater kudu Tragelaphus strepsiceros 
 Lesser kudu Tragelaphus imberis 
 Markhor Capra falconeri 
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 Mishmi takin Budorcas taxicolor taxicolor 
 Rocky Mountain goat Oreamnos americanus 
Canidae 
 Bush dog Speothos venaticus 
 European grey wolf Canis lupus lupus 
 Fennec fox Vulpes zerda 
 Maned wolf Chrysocyon brachyurus 
 Red fox Vulpes vulpes 
Camelidae 
 Alpaca  Lama pacos domesticus 
 Bactrian camel Camelus bactrianus 
 Vicugna Vicugna vicugna 
Castordiae 
 Amercian beever Castor canadensis 
 Eurasian red squirrel Sciurus vulgaris 
Cebidae 




 Drill Mandrillus leucophaeus 
 Gelada baboon Theropithecus gelada 
 Javan silvered leaf monkey Trachypithecus auratus 
 Japanese macaque Macaca fuscata 
 White-crowned mangabey Cercocebus atys lunulatus 
Cervidae 
 Mesopotamian fallow deer Dama mesopotamica 
Chinchillidae 
 Plains viscacha Lagostomus maximus 
Elephantidae 
 African elephant Loxodonta africana 
 Indian elephant Elephas maximus indicus 
Equidae 
 Dulmen pony Equus caballus caballus dulmen 
 Grevy’s zebra Equus grevyi 
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 Persian onager Equus hemionus onager 
 Poitou donkey Equus asinus domestic Poitou 
 Przewalski’s wild horse Equus caballus przewalskii 
 Somali wild ass Equus africanus somaliensis 
Felidae 
 Jaguar Panthera onca 
 Persian leopard Panthera pardus saxicolor 
 Serval Leptailurus serval 
 Snow leopard Uncia uncia 
 Sumatran tiger Panthera tigris sumatrae 
Giraffidae 
 Okapi Okapi johnstoni 
 Reticulated giraffe Giraffa camelopardalis reticulata 
Herpestidae 
 Banded mongoose Mungos mungo 
 Slender-tailed meerkat Suricata suricatta 
Hippopotamidae 
 Pigmy hippopotamus Choeropsis liberiensis liberiensis 
Hominidae 
 Bonobo Pan paniscus 
 Bornean orangutan Pongo pygmaeus 
 Chimpanzee Pan troglodytes 
 Lar gibbon Hylobates lar 
 Sumatran orangutan Pongo abelii 
 Western lowland gorilla Gorilla gorilla gorilla 
Hyaenidae 
 Spotted hyena Crocuta crocuta 
Hylobatidae 
 Lar gibbon Hylobates lar 
Macropodidae 
 Red kangaroo Macropus rufus 
Muridae 
 Norway rat Rattus norvegicus 
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 Norway rat Rattus norvegicus forma 
domestica 
Otariidae 
 California sea lion Zalophus californianus 
Phocidae 
 Harbor seal Phoca vitulina 
Pitheciidae 
 White-faced saki Pithecia pithecia 
Pteropus 
 Indian flying fox Pteropus giganteus 
Rhinocerotidae 
 One-horned rhinoceros Rhinoceros unicornis 
Suidae 
 African bush pig  Potamochoerus porcus pictus  
 Babirusa  Babyrousa babyrussa 
 Common warthog Phacochoerus africanus 
 Domestic pig  
(Kunekune pig) 
Sus scrofa scrofa kunekune 
 Domestic pig  
(Schwäbisch-Hall) 
Sus scrofa forma domestica 
 European wild boar Sus scrofa  
Tapiridae 
 Malayan tapir Tapirus indicus 
Tayasuidae 
 Collared peccary Pecari tajacu 
Tenrecidae   
 Common tenrec Tenrec ecaudatus 
Ursidae 
 Polar bear Ursus maritimus 
 South American coati Nasua nasua 
 Spectacled bear Tremarctos ornatus 
 Syrian brown bear Ursus arctos syriacus 
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